Pharmacokinetic Modeling of [
Histamine H3 receptor
[11C]GSK189254
kinetic modeling
pharmacokinetics
receptor imaging
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
07 03 2022
07 03 2022
Historique:
pubmed:
17
2
2022
medline:
12
4
2022
entrez:
16
2
2022
Statut:
ppublish
Résumé
The histamine H
Identifiants
pubmed: 35170965
doi: 10.1021/acs.molpharmaceut.1c00889
pmc: PMC8905578
doi:
Substances chimiques
Benzazepines
0
Carrier Proteins
0
Radiopharmaceuticals
0
Niacinamide
25X51I8RD4
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
5T4TX6CO53
Histamine
820484N8I3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
918-928Références
J Cereb Blood Flow Metab. 2017 Mar;37(3):1095-1107
pubmed: 27207170
J Pharmacol Exp Ther. 2011 Jan;336(1):38-46
pubmed: 20864505
Learn Mem. 2004 Jan-Feb;11(1):1-8
pubmed: 14747511
J Med Chem. 2012 Mar 8;55(5):2406-15
pubmed: 22313227
Drug Saf. 2006;29(11):1049-59
pubmed: 17061910
EJNMMI Res. 2018 Jun 14;8(1):48
pubmed: 29900481
Brain Res. 1996 Sep 23;734(1-2):316-8
pubmed: 8896839
J Anaesthesiol Clin Pharmacol. 2019 Apr-Jun;35(2):157-160
pubmed: 31303701
J Nucl Med. 2014 Jan;55(1):65-72
pubmed: 24263088
Prog Neurobiol. 2001 Apr;63(6):637-72
pubmed: 11164999
Br J Pharmacol. 1992 Dec;107(4):919-23
pubmed: 1334753
Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):633-8
pubmed: 2615855
Pharmacol Biochem Behav. 1995 Mar;50(3):321-5
pubmed: 7617668
Front Syst Neurosci. 2012 Oct 23;6:72
pubmed: 23109919
PLoS One. 2015 Nov 24;10(11):e0143900
pubmed: 26600165
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4713-8
pubmed: 22687746
Eur J Neurosci. 2004 Apr;19(7):1992-6
pubmed: 15078574
Neuroreport. 2000 Jan 17;11(1):163-6
pubmed: 10683850
Nucl Med Biol. 2000 Oct;27(7):661-70
pubmed: 11091109
Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):513-9
pubmed: 1965326
Neuropharmacology. 2016 Jul;106:91-101
pubmed: 26169221
Neuropharmacology. 2012 Feb;62(2):1127-33
pubmed: 22115898
Neuroimage. 2005 Jan 1;24(1):1-11
pubmed: 15588591
Br J Pharmacol. 2014 Mar;171(5):1241-9
pubmed: 24670146
J Biol Chem. 2000 Nov 24;275(47):36781-6
pubmed: 10973974
J Cereb Blood Flow Metab. 1983 Jun;3(2):254-6
pubmed: 6841473
Br J Pharmacol. 2020 Aug;177(15):3464-3472
pubmed: 32293706
Trends Pharmacol Sci. 2004 Dec;25(12):618-25
pubmed: 15530639
ACS Chem Neurosci. 2016 Feb 17;7(2):177-84
pubmed: 26529287
Neuropharmacology. 2007 Feb;52(2):527-35
pubmed: 17027043
CNS Neurosci Ther. 2011 Dec;17(6):620-8
pubmed: 22070192
Synapse. 2009 Dec;63(12):1122-32
pubmed: 19670309
Br J Pharmacol. 1995 Apr;114(7):1518-22
pubmed: 7606356
J Pharmacol Exp Ther. 1994 Oct;271(1):452-9
pubmed: 7965746
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1653-63
pubmed: 26902370
Bioorg Med Chem. 1999 Sep;7(9):1761-7
pubmed: 10530922
J Pharmacol Exp Ther. 1998 Nov;287(2):658-66
pubmed: 9808693
Trends Pharmacol Sci. 2011 Apr;32(4):242-9
pubmed: 21324537
J Neurosci. 2006 Oct 4;26(40):10292-8
pubmed: 17021184
J Nucl Med. 2009 Dec;50(12):2064-72
pubmed: 19910432
Sci Rep. 2017 Jan 11;7:39934
pubmed: 28074918
Nucl Med Biol. 2007 Nov;34(8):981-7
pubmed: 17998102
Int J Neuropsychopharmacol. 2013 Jul;16(6):1231-9
pubmed: 23217964
Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):588-90
pubmed: 3412497
Nucl Med Biol. 2006 Aug;33(6):801-10
pubmed: 16934699
J Pharmacol Exp Ther. 2003 Jun;305(3):897-908
pubmed: 12606600
Neuroscience. 2002;114(1):173-93
pubmed: 12207964
Behav Brain Res. 2016 Oct 1;312:415-30
pubmed: 27363923
Mol Interv. 2006 Apr;6(2):77-88, 59
pubmed: 16565470
Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):558-64
pubmed: 10598795
J Nucl Med. 2010 Jul;51(7):1021-9
pubmed: 20554726
Brain. 1990 Feb;113 ( Pt 1):27-47
pubmed: 2302536